Kamada (KMDA) Enterprise Value (2012 - 2026)
Kamada's (KMDA) quarterly Enterprise Value came in at -$73.1 million in Q1 2026, up 4.07% YoY from -$70.3 million in Q1 2025, and up 3.33% on a QoQ basis from -$75.7 million in Q4 2025.
Kamada (KMDA) Enterprise Value (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Enterprise Value data on file, last reported at -$73.1 million in Q1 2026.
- Quarterly Enterprise Value rose 4.07% year-over-year to -$73.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$73.1 million (up 4.07% YoY) and the FY2025 annual result came in at -$75.7 million, up 3.59% from the prior year.
- Enterprise Value grew to -$73.1 million in Q1 2026, from -$75.7 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$29933.0 in Q2 2022 to a low of -$31.3 billion in Q3 2022.
- A 5-year average of -$1.9 billion and a median of -$56.5 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 99.97% — and 2023, when it slumped 72689.23%.
- Tracing KMDA's Enterprise Value over 5 years: stood at -$34.3 million in 2022, then slumped by 62.83% to -$55.8 million in 2023, then tumbled by 40.68% to -$78.5 million in 2024, then grew by 3.59% to -$75.7 million in 2025, then advanced by 3.33% to -$73.1 million in 2026.
- The last three Enterprise Value figures came in at -$73.1 million (Q1 2026), -$75.7 million (Q4 2025), and -$72.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Kamada | 465.78 Mn | 436.31 Mn | 22.47 Mn | -29.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -70.13 Mn |
| Mar 31, 2026 | -73.15 Mn |
| Dec 31, 2025 | -75.67 Mn |
| Sep 30, 2025 | -72.00 Mn |
| Jun 30, 2025 | -65.99 Mn |
| Mar 31, 2025 | -76.25 Mn |
| Dec 31, 2024 | -78.48 Mn |
| Sep 30, 2024 | -72.00 Mn |
| Jun 30, 2024 | -56.55 Mn |
| Mar 31, 2024 | -48.19 Mn |
| Dec 31, 2023 | -55.79 Mn |
| Sep 30, 2023 | -52.60 Mn |
| Jun 30, 2023 | -21.79 Mn |
| Mar 31, 2023 | -27.12 Mn |
| Dec 31, 2022 | -34.26 Mn |
| Sep 30, 2022 | -31.25 Bn |
| Jun 30, 2022 | -29,933.00 |
| Mar 31, 2022 | -21.97 Mn |
| Dec 31, 2021 | -145.29 Mn |
| Sep 30, 2021 | -99.84 Mn |